Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
The Oncologist|June 17, 2016
Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse EventsElisa González-Rodríguez, Delvys Rodríguez-Abreu,
Oncology and Therapy|February 14, 2021
Practical Issues in the Use of Atezolizumab for Patients with Non-Small Cell Lung Cancer: Case Reports and Literature ReviewManuel Cobo, Delvys Rodríguez-Abreu, Diego Pérez Parente, et al.
JTO Clinical and Research Reports|November 21, 2022
Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189Shirish Gadgeel, Jhanelle E Gray, Maria Teresa Rizzo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2010
SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphomaDelvys Rodríguez-Abreu, Marta Llanos Muñoz, Mariano Provencio Pulla, et al.
Cancer Treatment Reviews|January 28, 2024
The state of the art of EGFR exon 20 insertions in non-small cell lung cancer: Diagnosis and future perspectivesMiriam Dorta-Suárez, Maria de Miguel, Oscar Amor-Carro, et al.
Reumatologia Clinica|November 26, 2018
Immunotherapy, Cancer and Rheumatological Diseases: A Review of the Literature and a Series of Cases in a University HospitalFrancisco Javier Nóvoa Medina, Beatriz Tejera Segura, Elisa González Rodríguez, et al.
Aging Clinical and Experimental Research|July 31, 2024
Influence of serum uric acid on bone and fracture risk in postmenopausal womenMaría-Jesús Gómez-de-Tejada-Romero, Carmen Murias-Henríquez, Pedro Saavedra-Santana, et al.
Antioxidants (Basel, Switzerland)|November 30, 2019
Modulation of Oxidative Stress by Ozone Therapy in the Prevention and Treatment of Chemotherapy-Induced Toxicity: Review and ProspectsBernardino Clavo, Francisco Rodríguez-Esparragón, Delvys Rodríguez-Abreu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 20, 2024
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-UpShirish M Gadgeel, Delvys Rodríguez-Abreu, Balazs Halmos, et al.
Leukemia & Lymphoma|February 28, 2007
Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patientsElías Gracia, Patrizia Froesch, Luca Mazzucchelli, et al.
Pageof 8